Etiometry Expands its Clinical Decision-Support Software with a NICU Focus
News and Press Releases
BOSTON, September 1st, 2020 – Etiometry, Inc., the leader in clinical decision-support software for the intensive care environment, is expanding their efforts into neonatal intensive care units. The announcement comes as Etiometry recognizes the work and dedication of clinicians improving the health of the most vulnerable patients during NICU Awareness Month, which kicks-off today.
Advancements in monitoring and support technologies have aided clinicians in improving the care they deliver and the impact they have had in improving the health and outcomes of NICU patients. Etiometry is focused on delivering technologies to further aid NICU clinicians in identifying and managing patients at risk of hemodynamic and respiratory instability to avoid complications and speed recovery.
WATCH THIS: Etiometry Supporting NICU Initiatives
“These are arguably the most delicate patients to treat and we do not take that responsibility lightly. The Etiometry Platform provides clinicians with easy access and visibility to available patient data when and where it is needed for critical decision support, as well as determining the progress of the patient’s condition,” explained Etiometry’s CEO, Shane Cooke.
The Etiometry Platform harnesses patient data to create novel risk indices for clinicians to better identify trending stages of clinical deterioration to improve the quality of care and health of individual patients. Etiometry is the first company to earn FDA-clearance for two critical care risk indices for patients under 12 years old.
NICU Awareness Month was created to celebrate the clinicians who take care of the tiniest patients and the families who never leave their side during a difficult journey. To support NICU Awareness Month, please join Etiometry in wearing green and using the hashtag #NICUAwarenessMonth.
About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com
Related
Boston Children’s Hospital Multi-center Study Finds Etiometry’s Risk Analytics Algorithms May Help Assess Extubation Failure Following Congenital Cardiac Surgery
Results published in Pediatric Critical Care Medicine demonstrate that the IDO2 and IVCO2 Indices may support more informed ventilator liberation decisions May 19, 2025 – BOSTON – A newly published multi-center study has found that Etiometry’s FDA-cleared physiologic risk analytics—IDO2 and IVCO2—were found to be associated with increased risk of extubation failure in retrospective analysis, […]
Health Tech: Shane Cooke Of Etiometry On How Their Technology Can Make An Important Impact On Our Overall Wellness
An Interview With David Leichner published by Authority Magazine From discussing the five things every health tech founder should know, to the real-world impact of Etiometry’s technology in the ICU, this piece offers a compelling look into the mission driving our team forward every day. Read the full interview HERE
Recent Data Highlights the Critical Role of the Etiometry Platform in Assessing Compliance and Opportunities for Improvement in Neonatal Oxygen Therapy
Abstract presented at the 2025 Pediatric Academic Societies (PAS) Annual Meeting April 28, 2025 – BOSTON – A recent study conducted at Children’s National Hospital in Washington, D.C., examined the role of Etiometry’s near real-time clinical intelligence platform in assessing neonatal oxygen therapy compliance and identifying potential areas for improvement. The findings were presented this […]